[News] Evolving role of rituximab in leukaemia and lymphoma

01:42 EDT 17 Aug 2012 | The Lancet

Rituximab, the first monoclonal antibody to be approved for treatment of any type of cancer, has changed the therapeutic standard for lymphoma and leukaemia. Its role in the treatment of these two disorders has evolved further as researchers have exp..

Original Article: [News] Evolving role of rituximab in leukaemia and lymphoma

More From BioPortfolio on "[News] Evolving role of rituximab in leukaemia and lymphoma"

Biotech & Healthcare Channels World News Life Science Events Corporate Database Market Reports Categories

Search BioPortfolio:

Clinical Trials - Daily Updated Database search the latest medical and pharmaceutical trials.

Drugs Database search our comprehensive database of prescription drugs.

Research Literature - Daily Updated Database search biomedical papers and journals.

News Quicklinks

Search Biotech, Medical and Healthcare News

Biotech News by Article Type

Biotech News by Location

BioPortfolio Bloggers

Publishing Your News on BioPortfolio

Recent Visitor News Searches

Searches Linking to this Story

double hit lymphoma

Latest Biotechnology, Pharmaceutical and Healthcare News

Research Roundup: State Gun Laws And Death Rates; Getting A Critical Care Doc At Night; Poverty Among Seniors

Impax Laboratories to Present at the Deutsche Bank 38th Annual Health Care Conference

Viewpoints: We Need More 'Socialism'; The IRS's 'Unwelcome Role'; 'Fog Of Obamacare'

Highlights: States Delay Or Drop Dual-Eligible Pilot Program; La. Grand Jury To Examine $200M Medicaid Contract; Examining Insurer Earnings In Ore.

House Panel Considers Measure That Would Ban Abortions After 20 Weeks

Tensions, Threats Emerge In Ariz. Medicaid Expansion Debate

California Unveils Tentative Price Tags Of Insurance Plans On Health Exchange

BioPortfolio Limited

Publish Content

Agreements

Tools

Help

This site complies with the HONcode standard for trustworthy health information:
Verify here.

The information provided by BioPortfolio.com is not a substitute for professional medical advice, diagnosis or treatment. The BioPortfolio site is sponsored BioPortfolio Limited with offices at Stafford House, 10 Prince of Wales Road, Dorchester, DT1 1PW, England. If you are a legal copyright holder or a designated agent for such and you believe a post on this website falls outside the boundaries of “Fair Use” and legitimately infringes on your or your client's copyright we may be contacted concerning copyright matters at: priority@bioportfolio.com.
All rights reserved. All other trademarks recognized. Copyright © 1997-2013 BioPortfolio Limited. Site developed by Alacrify Ltd.